AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANT

This adverse event was reported 89 times

These drugs are most commonly taken by patients reporting AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANT:

# Drug Count
0 DEXAMETHASONE 42
1 DEXAMETHASONE 1.5 MG 42
2 VENETOCLAX 33
3 BORTEZOMIB 30
4 DARATUMUMAB 25
5 LENALIDOMIDE 25
6 ETOPOSIDE 21
7 RITUXIMAB 20
8 CARBOPLATIN 19
9 METHOTREXATE 19
See all common drugs associated with AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANT

AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ILOPROST 1 0.0011
1 CARMUSTINE 5 0.0011
2 NELARABINE 1 0.0010
3 OBINUTUZUMAB 14 0.0008
4 IFOSFAMIDE FOR INJECTION 16 0.0007
5 TEMOZOLOMIDE 14 0.0007
6 THIOTEPA 6 0.0006
7 VENETOCLAX 33 0.0005
8 CEFTAZIDIME 4 0.0005
9 MELPHALAN HYDROCHLORIDE 13 0.0005
See all drugs enriched for association with AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANT

AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD38-directed Cytolytic Antibody [EPC] 25 0.0043
1 Prostacycline [EPC] 1 0.0011
2 BCL-2 Inhibitor [EPC] 33 0.0005
3 Proteasome Inhibitor [EPC] 32 0.0003
4 Topoisomerase Inhibitor [EPC] 21 0.0003
5 Tetracycline-class Drug [EPC] 13 0.0002
6 Penem Antibacterial [EPC] 5 0.0001
7 Alkylating Drug [EPC] 31 0.0001
8 Aminoglycoside Antibacterial [EPC] 4 0.0001
9 Platinum-based Drug [EPC] 23 0.0001
See all drug classes enriched for association with AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANT